Aqueous Cinnamon Extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Koppikar, Soumya J ^a   Choudhari, Amit S ^a   Suryavanshi, Snehal A ^a   Kumari, Shweta ^a   Chattopadhyay, Samit ^b   Kaul Ghanekar, Ruchika ^a  

^a Bharati Vidyapeeth Deemed University   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CINNAMOMUM CASSIA EXTRACT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; GELATINASE A; MESSENGER RNA; POLYPHENOL; ACROLEIN; ANTINEOPLASTIC AGENT; CINNAMALDEHYDE; DRUG DERIVATIVE; FLAVONOID; HER2 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; PHENOL DERIVATIVE; PLANT EXTRACT; POLYPHENOLS;

AGAR MEDIUM; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BARK; CALCIUM SIGNALING; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL VIABILITY; CINNAMOMUM CASSIA; COLONY FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; FLUORESCENCE ACTIVATED CELL SORTING; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; UTERINE CERVIX CANCER; WOUND HEALING; ZYMOGRAPHY; CELL MOTION; CELL PROLIFERATION; CELL SEPARATION; CHEMISTRY; CINNAMOMUM AROMATICUM; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENETICS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MITOCHONDRION; PATHOLOGY; THIN LAYER CHROMATOGRAPHY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ACROLEIN; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; CHROMATOGRAPHY, THIN LAYER; CINNAMOMUM AROMATICUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; KINETICS; MATRIX METALLOPROTEINASE 2; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MITOCHONDRIA; PHENOLS; PLANT BARK; PLANT EXTRACTS; RECEPTOR, ERBB-2; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 77954302270     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-210     Document Type: Article

References (57)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA: A Cancer. Journal for Clinicians 2005, 55:74-108.
2. Adams M, Jewell AP. The use of complementary and alternative medicine by cancer patients. Int Semin Surg Oncol 2007, 4:10. Published online 2007 April 30. doi: 10.1186/1477-7800-4-10, 10.1186/1477-7800-4-10, 1872026, 17470282.
3. Matthews AK, Sellergren SA, Huo D, List M, Fleming G. Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 2007, 13:555-562. 10.1089/acm.2007.03-9040, 17604560.
4. Rocha ABDA, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 2001, 1:364-369. 10.1016/S1471-4892(01)00063-7, 11710734.
5. Mann J. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2002, 2:143-148. 10.1038/nrc723, 12635177.
6. Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 2007, 16:1753-1773. 10.1517/13543784.16.11.1753, 17970636.
7. Abdullaev FI. Cancer Chemopreventive and Tumoricidal Properties of Saffron (Crocus sativus L.). Exp Biol Med 2002, 227:20-25.
8. Banerjee S, Panda CK, Das S. Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis 2006, 27:1645-1654. 10.1093/carcin/bgi372, 16501250.
9. Cvoro A, Paruthiyil S, Jones JO, Tzagarakis-Foster C, Clegg NJ, Tatomer D, Medina RT, Tagliaferri M, Schaufele F, Scanlan TS, Diamond MI, Cohen I, Dale C. Selective Activation of Estrogen Receptor-Transcriptional Pathways by an Herbal Extract. Leitman Endocrinology 2007, 148:538-547.
10. Kwon HK, Jeon WK, Hwang JS, Lee CG, So JS, Park JA, Ko BS, Im SH. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. Cancer Letters 2009, 278:174-82. 10.1016/j.canlet.2009.01.015, 19203831.
11. Gratus C, Wilson S, Greenfield SM, Damery SL, Warmington SA, Grieve R, Steven NM, Routledge P. The use of herbal medicines by people with cancer: a qualitative study. BMC Complementary and Alternative Medicine 2009, 9:1-7. 10.1186/1472-6882-9-14, 2647521, 19144128.
12. Saxena A, Dixit S, Aggarwal S, Seenu V, Prashad R, Bhushan SM, Tranikanti V, Misra MC, Srivastava A. An Ayurvedic Herbal Compound to reduce Toxicity to Cancer chemotherapy: A Randomized Controlled Trial. Indian Journal of Medical & Paediatric Oncology 2008, 29:11-18.
13. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AMA, Platin N, Kearney N, Patiraki E. Use of complementary and alternative medicine in cancer patients: a European survey. Annals of Oncology 2005, 16:655-663. 10.1093/annonc/mdi110, 15699021.
14. Lee SH, Lee SY, Son DJ, Lee H, Yoo HS, Song S, Oh KW, Han DC, Kwon BM, Hong JT. Inhibitory effect of 20-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-[kappa]B activation in RAW 264.7 cells. Biochem Pharmacol 2005, 69:791-799. 10.1016/j.bcp.2004.11.013, 15710356.
15. Singh G, Maurya S, delampasona MP, Catalan CAN. A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents. Food Chem Toxicol 2007, 45:1650-1661. 10.1016/j.fct.2007.02.031, 17408833.
16. Lee J-S, Jeon S-M, Park E-M, Huh T-L, Kwon O-S, Lee M-K, Choi M-S. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterolfed rats. J Med Food 2003, 6:183-191. 10.1089/10966200360716599, 14585184.
17. Matan N, Rimkeeree H, Mawson AJ, Chompreeda P, Haruthaithanasan V, Parker M. Antimicrobial activity of cinnamon and clove oils under modified atmosphere conditions. Int J Food Microbiol 2006, 107:180-185. 10.1016/j.ijfoodmicro.2005.07.007, 16266767.
18. Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diab Care 2003, 26:3215-3218.
19. Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol 2006, 104:119-123. 10.1016/j.jep.2005.08.059, 16213119.
20. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diab Res Clin Pract 2003, 62:139-148.
21. Schoene NW, Kelly MA, Polansky MM, Anderson RA. Watersoluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer Letter 2005, 230:134-140.
22. Kamei T, Kumano H, Iwata K, Nariai Y, Matsumoto T. The effect of a traditional Chinese prescription for a case of lung carcinoma. J Alternat Complemen Med 2000, 6:557-559.
23. Singh R, Koppikar SJ, Paul P, Gilda S, Paradkar AR, Kaul-Ghanekar R. Comparative analysis of cytotoxic effect of aqueous cinnamon extract from Cinnamomum zeylanicum bark with commercial cinnamaldehyde on various cell lines. Phar Bio 2009,
24. Lee CW, Hong DH, Han SB, Park SH, Kim HK, Kwon BM, Kim HM. Inhibition of human tumor growth by 20-hydroxy- and 20-benzoyloxycinnamaldehydes. Planta Med 1999, 65:263-266. 10.1055/s-2006-960772, 10232076.
25. The Ayurvedic Pharmacopoeia of India Part-I Volume-I first edition.
26. Gopu CL, Aher S, Mehta H, Paradkar AR, Mahadik KR. Simultaneous determination of cinnamaldehyde, eugenol and piperine by HPTLC densitometric method. Phytochemical Analysis 2008, 19:116-21. 10.1002/pca.1022, 17853382.
27. Kaul R, Mukherjee S, Ahmed F, Bhat MK, Chhipa R, Galande S, Chattopadhyay S. Int J Cancer 2003, 103:606-615. 10.1002/ijc.10881, 12494467.
28. Rangaswami H, Bulbule A, Kundu GC. : Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IκBα kinase-dependent nuclear factor κB-mediated promatrix metalloproteinase-9 activation. The Journal of Biological Chemistry 2004, 279:38921-38935. 10.1074/jbc.M404674200, 15247285.
29. Yoon MJ, Lee HJ, Kim J-H, Kim DK. Extracellular ATP Induces Apoptotic Signaling in Human Monocyte Leukemic Cells, HL-60 and F-36P. Arch Pharm Res 2006, 29:1032-1041. 10.1007/BF02969288, 17146973.
30. Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. British Journal of Cancer 2002, 86:443-448. 10.1038/sj.bjc.6600079, 2375221, 11875713.
31. Chavez-Blanco A, Perez-Sanchez V, Gonzalez-Fierro A, Vela-Chavez T, Candelaria M, Cetina L, Vidal S, Dueñas-Gonzalez A. HER2 expression in cervical cancer as a potential therapeutic target. BMC Cancer 2004, 4:1-6. 10.1186/1471-2407-4-59, 317471, 14725718.
32. Rocca GL, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. British Journal of Cancer 2004, 90:1414-1421. 10.1038/sj.bjc.6601725, 2409673, 15054465.
33. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis. Clinical Cancer Research 2004, 10:7621-7628. 10.1158/1078-0432.CCR-04-1061, 15569994.
34. D'herbe K, Leybaert L. Intracellular free calcium related to apoptotic cell death in quail granulosa cell sheets kept in serum-free culture. Cell Death Differ 1997, 4:59-65. 10.1038/sj.cdd.4400201, 16465211.
35. Kaddour-Djebbar I, Lakshmikanthan V, Shirley RB, Ma Y, Lewis RW, Vijay M. Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. Mol Cancer Ther 2006, 5:1958-1966. 10.1158/1535-7163.MCT-06-0011, 16928816.
36. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995, 1241:139-76.
37. Werth JL, Thayer SA. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 1994, 14:348-56.
38. Herrington J, Park YB, Babcock DF, Hille B. Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells. Neuron 1996, 16:219-28. 10.1016/S0896-6273(00)80038-0, 8562086.
39. Kruman II, Mattson MP. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem 1999, 72:529-40. 10.1046/j.1471-4159.1999.0720529.x, 9930724.
40. Meijerman I, Beijnen JH, Schellens JHM. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006, 11:742-752. 10.1634/theoncologist.11-7-742, 16880233.
41. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Research 1986, 46:1-7. full_text, 2998604.
42. Overall CM, Lo'pez-Oti{dotless}'n C. Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat Rev Cancer 2002, 2:657-672. 10.1038/nrc884, 12209155.
43. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348. 10.1038/35077213, 11357141.
44. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signaling. Nat Rev Mol Cell Biol 2000, 1:11-21. 10.1038/35036035, 11413485.
45. Sareen D, Darjatmoko SR, Albert DM, Polans AS. Mitochondria, Calcium, and Calpain are Key Mediators of Resveratrol-Induced Apoptosis in Breast Cancer. Mol Pharmacol 2007, 72:1466-1475. 10.1124/mol.107.039040, 17848600.
46. Bode AM, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 2004, 555:33-51.
47. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. The antitumor activities of flavonoids. In Vivo 2005, 19:895-909.
48. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher J. Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 2007, 120:451-8. 10.1002/ijc.22419, 17131309.
49. Panickar KS, Polansky MM, Anderson RA. Cinnamon polyphenols attenuate cell swelling and mitochondrial dysfunction following oxygen-glucose deprivation in glial cells. Experimental Neurology 2009, 216:420-427. 10.1016/j.expneurol.2008.12.024, 19166834.
50. D'Archivio M, Santangelo C, Scazzocchio B, Varì R, Filesi C, Masella R, Giovannini C. Modulatory Effects of Polyphenols on Apoptosis Induction: Relevance for Cancer Prevention. Int J Mol Sci 2008, 9:213-228. 10.3390/ijms9030213, 2635670, 19325744.
51. Raval AP, Dave KR, Pérez-Pinzón MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2006, 26:1141-1147.
52. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002, 71:655-665. 10.1016/S0024-3205(02)01691-0, 12072154.
53. Inoue H, Jiang X, Katayama T, Osada S, Umesono K, Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 2003, 352:203-206. 10.1016/j.neulet.2003.09.001, 14625020.
54. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007, 12:4839-54. 10.2741/2432, 17569614.
55. Cragg GM, Kingston DGI, Newman DJ. Anticancer agents from natural products. 2005, Taylor and Francis Group, Brunner-Routledge Psychology Press, London.
56. Newman DJ, Cragg GM, Snader KM. Natural products as a source of new drugs over the period 1981-2002. J Nat Prod 2003, 66:1022-1037. 10.1021/np030096l, 12880330.
57. Balachandran P, Govindarajan R. Cancer-an ayurvedic perspective. Pharmacological Research 2005, 51:19-30.